Development of a Quantitative Tissue Optical Index of Breast Density For Prediction of Hormone Therapy Response

Withdrawn before enrolling

Conditions studied: Accessory; Breast Tissue

In brief

The purpose of this research study is to investigate whether breast density measured by a safe, painless imaging method (called Diffuse Optical Spectroscopic Imaging - DOSI) can detect the decrease of breast density in subjects who receive tamoxifen when compared to patients who do not receive any drug. If decreased density can be reliably detected, it may help determine which subjects will benefit by taking tamoxifen or other chemoprevention drugs.

Key facts

Study ID

NCT01773551

Run by

University of California, Irvine

People needed

0

Starts

2012-04-01

Expected to finish

2018-04-01

Last updated by the study team

2022-11-02

Who can join

Age: 21 and older, up to 50. Sex: female. Healthy volunteers: accepted.

Where it is running

• Pacific Breast Care Medical Clinic — Costa Mesa, California, United States
• Beckman Laser Institute Medical Clinic — Irvine, California, United States
• Chao Family Comprehensive Cancer Center — Orange, California, United States
• Helen Diller Family Comprehensive Cancer Center/ UCSF — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.